Under this agreement, MaxCyte’s second signed with a U.S. NIH institute in the past year, the Company and the National Heart, Lung, and Blood Institute will explore development of new therapies for sickle cell disease using MaxCyte’s gene-correction platform Gaithersburg, Maryland – MaxCyte, Inc. today announces it has entered into a Cooperative Research and Development Agreement (“CRADA”) […]
Public-private alliances will create world-leading genomics campus and accelerate commercialization Manchester, United Kingdom, and Hilden, Germany – QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced a partnership with multiple organizations to support creating a global genomics campus in Manchester, U.K., for innovation, life sciences, translational science and molecular diagnostics. QIAGEN is working with Health […]
FORT COLLINS, Colo. — KromaTiD, Inc. announced today that it has joined the National Institute of Standards and Technology Genome Editing Consortium, a newly launched public/private partnership (https://www.nist.gov/programs-projects/nist-genome-editing-consortium). The Consortium supports the emerging gene editing market and regulatory agency needs for standardized measurements of gene edits, editing by-products and the risks of utilizing genome editing technologies in research, […]
908 Devices, a pioneer of purpose-built analytical devices for chemical and biomolecular analysis, today announced a joint innovation partnership with Hangzhou Just Biotherapeutics (HJB). HJB is an integrated design company focused on technologies that will accelerate development of biotherapeutics and reduce manufacturing costs to make medicines more readily available in the global marketplace. HJB partners with […]
THOROLD, ON – Diversigen Inc. (Houston, TX) and Norgen Biotek Corp. (Ontario, Canada) today announced that they have entered into a strategic partnership through which industry and academic researchers will benefit from comprehensive end-to-end logistical, sequencing, and analytical solutions to meet the growing needs for microbiome analyses. Together, the two companies will provide a combined […]
Consortium chooses Genedata Selector as bioinformatics solution for production of industrial polyketides. Munich, Germany Genedata, a leading provider of advanced software solutions for R&D, today announced that the MyBio consortium has chosen Genedata Selector® as its genome management and characterization platform to support its highly innovative R&D work in antibiotics. MyBio is an interdisciplinary consortia […]
PALO ALTO, Calif.–Science Exchange, the leading marketplace for outsourced R&D™, announces a collaboration with LI-COR Biosciences to offer a suite of molecular imaging services based on LI-COR’s pioneer work in near-infrared fluorescence as a detection method. Based in Lincoln, Nebraska, LI-COR Biosciences is a world leader in innovative imaging systems for proteomics and pre-clinical research. With […]
Sysmex Corporation (HQ: Kobe, Japan; Chairman and CEO: Hisashi Ietsugu) has established a new subsidiary in Egypt and will begin conducting direct sales and services with the aim of expanding its business in the Middle East. In recent years, Egypt has been setting up healthcare infrastructure in line with the country’s economic expansion and population […]
SOMERSET, N.J. – Catalent Pharma Solutions, the leading global provider of advanced delivery technologies and development solutions for drugs, biologics and consumer health products, and Berkeley Lights, Inc. (BLI), a leader in digital cell biology, today announced Catalent Biologics will adopt BLI’s Beacon®optofluidic platform to accelerate Catalent Biologics’ cell line development workflow. The Beacon platform is […]
ANTWERP, Belgium–International Conference on Prenatal Diagnosis and Therapy (ISPD), Booth #15–PerkinElmer, Inc., a global leader committed to innovating for a healthier world, today announced a collaboration with Women & Infants Hospital (WIH) of Rhode Island, a Care New England hospital, to evaluate an innovative test method using the Vanadis®NIPT system, PerkinElmer’s Vanadis NIPT system is under development […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
